Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 81,387 | 213,246 | 205,547 | 196,652 | 214,432 |
| Cost of Goods | 36,340 | 81,767 | 81,829 | 79,612 | 81,930 |
| Gross Profit | 45,047 | 131,479 | 123,718 | 117,040 | 132,502 |
| Operating Expenses | -17,761 | 163,387 | 118,991 | 119,842 | 114,874 |
| Operating Income | 63,148 | -31,141 | 5,556 | -2,190 | 18,558 |
| Interest Expense | 4,644 | 5,316 | 4,965 | 4,800 | 1,656 |
| Other Income | 4,292 | -225 | -18 | -911 | -291 |
| Pre-tax Income | 62,796 | -36,682 | 573 | -7,901 | 16,611 |
| Income Tax | 5,931 | -6,352 | -947 | -1,873 | 3,825 |
| Net Income Continuous | 56,865 | -30,330 | 1,520 | -6,028 | 12,786 |
| Net Income | $13,771 | $-30,330 | $1,520 | $-6,028 | $12,786 |
| EPS Basic Total Ops | 0.26 | -0.55 | 0.03 | -0.11 | 0.23 |
| EPS Basic Continuous Ops | 1.01 | -0.54 | 0.03 | -0.11 | 0.23 |
| EPS Diluted Total Ops | 0.26 | -0.55 | 0.03 | -0.11 | 0.23 |
| EPS Diluted Continuous Ops | 1.01 | -0.54 | 0.03 | -0.11 | 0.23 |
| EBITDA(a) | $59,057 | $-18,858 | $18,741 | $9,744 | $32,669 |